Dudediligence.

Cardio Diagnostics Holdings, Inc

CDIONASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$6,580Sep ’24$4,512Dec ’24$940.00Mar ’25$7,475Jun ’25$2,855Sep ’25$3,555Dec ’25$2,680Mar ’26$5,360Jun ’26
Net income, by quarter
−$1.4MSep ’24−$1.5MDec ’24−$1.6MMar ’25−$1.7MJun ’25−$1.7MSep ’25−$1.5MDec ’25−$1.8MMar ’26−$1.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$901.00$950.00$17,065$34,890$14,825
Operating income−$620,448−$4.5M−$7.2M−$8.4M−$6.5M
Net income−$620,448−$4.7M−$8.4M−$8.4M−$6.5M
Operating cash flow−$585,291−$5.1M−$5.7M−$5.0M−$5.7M
Free cash flownone on filenone on file−$6.2M−$5.2M−$5.9M
Cash$512,767$4.1M$1.3M$7.8M$0.00
Shares outstanding1.2M9.5M20.5M1.5M1.8M